MedPath

Radiofrequenccy Ablation Combined with Hepatic Arterial Embolization using Degradable Starch Microsphere-MitomycinC for the Treatment of Liver Metastasis from Colorectal cancer.

Phase 2
Conditions
Colorectal cancer liver metastasis
Registration Number
JPRN-UMIN000006404
Lead Sponsor
Japanese College of Radiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1) Uncontrollable extrahepatic metastasis. 2) Venous invasion. 3) Artrial-portal or -venous shunting. 4) Hepatic arterial obstruction that may prevent embolization. 5) History of billiary surgery. 6) Tumors are close to the bowel and it is difficult to separate them. 7) Herat failure, Renal failure, and active infection, GI bleeding, double cancers, mental disease. 8) Fever (>38 degree celcius). 9) Allergy to contrast medium or mitomycinC. 10) Pregnant woman or woman who is willing to be pregnant. 11) Other reasons that a primary doctor judges judges as inappropriate for a candidate of thi study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath